Inflammatory mediators to predict left adverse ventricular remodelling in revascularized STEMI patients

Topic: Ischaemia, Infarction, Cardioprotection

Congress Presentation

About the speaker

Doctor Elisa Bevilacqua

Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, Seville (Spain)
1 presentation
0 follower

73 more presentations in this session

Silent myocardial infarction in non-insulin dependent type 2 diabetes mellitus patients with low adherence to blood glucose monitoring

Speaker: Doctor K. Viligorska (Chernivtsi, UA)


Implication of caveolae in the pathophysiology of human acute myocardial infarction: a histological study

Speaker: Mr C. Rios Navarro (Valencia, ES)


Ang 1-7 mitigates the thapsigargin induced lowered myocardium tolerance to ischemia and reperfusion

Speaker: Associate Professor L. Tacu (Chisinau, MD)


Searching for cardioprotective microRNA families by bioinformatics analysis of cross-species transcriptomic datasets

Speaker: Doctor B. Agg (Budapest, HU)


A novel receptor-interacting protein-1 (RIP1) inhibitor (547) protects human cardiac cells from ischemia/reperfusion-triggered necroptotic cell death

Speaker: Doctor M. Peters (Utrecht, NL)


Access the full session

Poster Session 1

Speakers: Doctor E. Bevilacqua, Doctor K. Viligorska, Mr C. Rios Navarro, Associate Professor L. Tacu, Doctor B. Agg...

About the event


Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb